secwatch.observer — SEC 8-K summary
======================================

Issuer:     SeaStar Medical Holding Corp (ICU)
CIK:        0001831868
Form:       8-K
Filed at:   2023-08-15T23:59:59+00:00
Accession:  0000950170-23-042572
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

SeaStar Medical Q2 net loss widens to $3.7M; cash at $13K; FDA setback on pediatric device
--------------------------------------------------------------------------------

- Net loss $3.7M ($0.25/sh) vs $0.9M ($0.12) in Q2 2022; R&D up to $2.0M, G&A $1.7M.
- Cash only $13K as of June 30; raised $3.3M convertible debt in March, $2.2M in May, $543K note in August.
- FDA HDE application for pediatric SCD-PED not approvable; working with FDA for resubmission.
- Two sites activated for adult NEUTRALIZE-AKI trial; expects SCD-ADULT approval H1 2025, launch H2 2025.
- Business update call on Aug 22, 2023 at 4pm ET.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1831868/000095017023042572/0000950170-23-042572-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1831868/000095017023042572/icu-20230814.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-042572

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer